CEFAMAX
CEFAMAX
Authorised
- Cefapirin benzathine
Product identification
Medicine name:
CEFAMAX
Active substance:
- Cefapirin benzathine
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefapirin benzathine300.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Meat and offalno withdrawal periodCarne: 14 días después del tratamiento
-
Milkno withdrawal periodLeche:Cero días tras parto, en período de secado superior a 5 semanas/24 horas (2 ordeños),en periodo de secado inferior a las 5 semanas.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB08
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Syva S.A.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 1682 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 11/07/2025
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
